Jonathan M. Poole has served as a director of Acadia since March 2026. View All Board of Directors
Mr. Poole has served as Senior Vice President, Finance at Vertex Pharmaceuticals, Inc. since March 2020, where he leads the global finance organization and has supported a period of significant R&D portfolio expansion, global commercial growth and diversification, and the execution and integration of multiple acquisitions.
Previously, Mr. Poole served as Chief Financial Officer of Evelo Biosciences, Inc. from March 2018 to March 2020 and as Chief Financial Officer of Genocea Biosciences, Inc. from April 2014 to March 2018. Earlier in his career, he held roles of increasing responsibility in finance and corporate development, including co-founding a biotechnology investment partnership in 1994.
Mr. Poole has also served as a director of Codiak Biosciences, Inc., where he was Chair of the Audit Committee.
Mr. Poole received a B.Sc. in Biological Sciences from Durham University in the United Kingdom and an M.B.A. from London Business School.